These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8118908)

  • 1. Cryoprotective effect of gelatin and albumin on recombinant human tumor necrosis factor liposome.
    Yasui K; Fujioka H; Nakamura Y
    Chem Pharm Bull (Tokyo); 1993 Dec; 41(12):2138-40. PubMed ID: 8118908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.
    Debs RJ; Fuchs HJ; Philip R; Brunette EN; Düzgüneş N; Shellito JE; Liggitt D; Patton JR
    Cancer Res; 1990 Jan; 50(2):375-80. PubMed ID: 2295077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release profiles of recombinant human tumor necrosis factor from Ca(2+)-triggering liposome in vivo.
    Yasui K; Fujioka H; Nakamura Y
    Biol Pharm Bull; 1996 Feb; 19(2):246-51. PubMed ID: 8850316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release by Ca(2+)-sensitive recombinant human tumor necrosis factor-alpha liposomes.
    Yasui K; Fujioka H; Nakamura Y
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):508-11. PubMed ID: 7774035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cryoprotective Agents in Liposome Stabilization and Preservation.
    Boafo GF; Magar KT; Ekpo MD; Qian W; Tan S; Chen C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers.
    Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Zhou JJ; Gao XJ
    J Control Release; 2001 Apr; 71(3):287-96. PubMed ID: 11295221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS; Crommelin DJ; Eling WM; Zuidema J
    J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
    Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Zhou JJ; Gao XJ; Zhu JH
    Biol Pharm Bull; 2001 Jun; 24(6):662-5. PubMed ID: 11411555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha.
    Sample AK; Czuprynski CJ
    J Leukoc Biol; 1991 Feb; 49(2):107-15. PubMed ID: 1846902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing cryoprotective activity and drug leakage from liposomes after freezing.
    Higgins J; Hodges NA; Olliff CJ; Phillips AJ
    J Pharm Pharmacol; 1986 Apr; 38(4):259-63. PubMed ID: 2872289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats.
    van der Veen AH; Eggermont AM; Seynhaeve AL; van Tiel ; ten Hagen TL
    Int J Cancer; 1998 Sep; 77(6):901-6. PubMed ID: 9714061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effects.
    Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Gao XJ; Zhu JH
    Biol Pharm Bull; 2001 Jun; 24(6):666-70. PubMed ID: 11411556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of modified betaines as cryoprotective additives.
    Lloyd AW; Olliff CJ; Rutt KJ
    J Pharm Pharmacol; 1994 Sep; 46(9):704-7. PubMed ID: 7837037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic evaluation of recombinant human tumor necrosis factor (TNF)-alpha, TNF-SAM2 and liposomal TNF-SAM2 in an anesthetized dog model.
    Lodato RF; Feig B; Akimaru K; Soma G; Klostergaard J
    J Immunother Emphasis Tumor Immunol; 1995 Jan; 17(1):19-29. PubMed ID: 7728303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
    Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of recombinant human tumor necrosis factor-alpha in rats. Effects of size and number of doses and nephrectomy.
    Ferraiolo BL; McCabe J; Hollenbach S; Hultgren B; Pitti R; Wilking H
    Drug Metab Dispos; 1989; 17(4):369-72. PubMed ID: 2571474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of liposomal-lipophilic tumor necrosis factor.
    Utsumi T; Hung MC; Klostergaard J
    Cancer Res; 1991 Jul; 51(13):3362-6. PubMed ID: 2054776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological change after local injection of liposomes containing tumor necrosis factor (TNF).
    Yasui K; Nakamura Y
    Biol Pharm Bull; 2000 Apr; 23(4):461-5. PubMed ID: 10784428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoprotective effects of cycloinulohexaose on freezing and freeze-drying of liposomes.
    Ozaki K; Hayashi M
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2116-20. PubMed ID: 8945777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.